ES2037055T3 - Procedimiento para la obtencion de 5-nitrobenzo(de)isoquinolin-1,3-dionas. - Google Patents

Procedimiento para la obtencion de 5-nitrobenzo(de)isoquinolin-1,3-dionas.

Info

Publication number
ES2037055T3
ES2037055T3 ES198787115310T ES87115310T ES2037055T3 ES 2037055 T3 ES2037055 T3 ES 2037055T3 ES 198787115310 T ES198787115310 T ES 198787115310T ES 87115310 T ES87115310 T ES 87115310T ES 2037055 T3 ES2037055 T3 ES 2037055T3
Authority
ES
Spain
Prior art keywords
dionas
nitrobenzo
isoquinolin
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787115310T
Other languages
English (en)
Spanish (es)
Inventor
Miguel Dr. Brana Fernandez
Jose Maria Dr. Berlanga Castellano
Marina Dr Moran Moset
Erich Dr. Schlick
Gerhard Dr. Keilhauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Application granted granted Critical
Publication of ES2037055T3 publication Critical patent/ES2037055T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES198787115310T 1986-10-21 1987-10-20 Procedimiento para la obtencion de 5-nitrobenzo(de)isoquinolin-1,3-dionas. Expired - Lifetime ES2037055T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863635711 DE3635711A1 (de) 1986-10-21 1986-10-21 5-nitrobenzo(de)isochinolin-1,3-dione, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
ES2037055T3 true ES2037055T3 (es) 1993-06-16

Family

ID=6312114

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787115310T Expired - Lifetime ES2037055T3 (es) 1986-10-21 1987-10-20 Procedimiento para la obtencion de 5-nitrobenzo(de)isoquinolin-1,3-dionas.

Country Status (9)

Country Link
US (1) US5552544A (enExample)
EP (1) EP0268093B1 (enExample)
JP (1) JPS63104963A (enExample)
AT (1) ATE76069T1 (enExample)
AU (1) AU592474B2 (enExample)
CA (1) CA1331382C (enExample)
DE (2) DE3635711A1 (enExample)
ES (1) ES2037055T3 (enExample)
ZA (1) ZA877859B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939372A1 (de) * 1989-11-29 1991-06-06 Knoll Ag Mitonafide-infusionsloesung
DE3942280A1 (de) * 1989-12-21 1991-06-27 Knoll Ag N-substituierte naphthalimide, ihre herstellung und verwendung
US5235045A (en) * 1992-03-19 1993-08-10 Microbiomed Corporation Non-azo naphthalimide dyes
US5766600A (en) * 1993-08-09 1998-06-16 Microbiomed Corporation Non-azo naphtalimide dyes and uses for same
EP0930883B1 (en) 1996-10-21 2006-01-11 Allelix Biopharmaceuticals Inc. Neurotrophin antagonists for the treatment of epilepsy, alzheimer's disease and pain
DE19714161A1 (de) * 1997-04-05 1998-10-08 Emtec Magnetics Gmbh Magnetischer Aufzeichnungsträger
JP2002537225A (ja) * 1998-11-25 2002-11-05 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 置換ベンゾ［ｄｅ］イソキノリン−１，３−ジオン類
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
US6468990B1 (en) * 1999-05-17 2002-10-22 Queen's University At Kingston Method of inhibiting binding of nerve growth factor to p75 NTR receptor
US6492380B1 (en) * 1999-05-17 2002-12-10 Queen's University At Kingston Method of inhibiting neurotrophin-receptor binding
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
DE60143911D1 (de) * 2000-11-06 2011-03-03 Pharma Mar Sa Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
DE10101319A1 (de) * 2001-01-09 2002-07-18 Schering Ag Morphometrisches Gewebe- oder Zellpräparat
GB0202544D0 (en) * 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
US6693198B2 (en) * 2002-04-22 2004-02-17 Xanthus Life Sciences, Inc. Amonafide salts
EP2305257A1 (en) * 2002-07-08 2011-04-06 ChemGenex Pharmaceuticals, Inc. Amonafide salts and compositions comprising same
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
WO2005049031A1 (en) * 2003-11-13 2005-06-02 Pharma Mar, S.A.U. Combination
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
CA2545054A1 (en) * 2003-11-14 2005-06-02 Pharma Mar, S.A. Combination therapy comprising the use of et-743 and paclitaxel for treating cancer
JP2007536283A (ja) * 2004-05-05 2007-12-13 ユニバイオスクリーン エス．アー． ナフタルイミド誘導体、それらの製造方法、およびそれらの医薬組成物
WO2006005602A2 (en) * 2004-07-09 2006-01-19 Pharma Mar, S.A. Use of ecteinascidin in the treatment of cancer in patients with low level of brca1
EP1812114A2 (en) * 2004-09-29 2007-08-01 Pharma Mar S.A., Sociedad Unipersonal Ecteinascidin compounds as anti-inflammatory agents
ES2326825T3 (es) * 2004-10-26 2009-10-20 Pharma Mar S.A., Sociedad Unipersonal Doxorubicina liposomal pegilada en combinacion con ecteinascidina 743.
EP1658848B1 (en) * 2004-10-29 2007-08-01 Pharma Mar S.A., Sociedad Unipersonal Formulations comprising ecteinascidin and a disaccharide
US7947839B2 (en) * 2004-12-01 2011-05-24 Genentech, Inc. Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
WO2007030939A2 (en) 2005-09-15 2007-03-22 Painceptor Pharma Corporation Methods of modulating neurotrophin-mediated activity
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
AU2007247355A1 (en) * 2006-05-05 2007-11-15 Unibioscreen S.A. 5-urea substituted naphthalimide derivatives, methods of production and pharmaceutical compositions for treating cancer
US20100267732A1 (en) * 2007-10-19 2010-10-21 Pharma Mar, S.A. Prognostic Molecular Markers for ET-743 Treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES459497A1 (es) * 1977-06-04 1978-04-16 Made Labor Sa Un metodo para la preparacion industrial de naftalimidas y sus derivados.
DE2944867A1 (de) * 1979-11-07 1981-05-27 Hoechst Ag, 6000 Frankfurt Kationische verbindungen der naphthalimid-reihe, verfahren zu deren herstellung und deren verwendung
US4614820A (en) * 1983-04-01 1986-09-30 Warner-Lambert Co. 3,6-disubstituted-1,8-naphthalimides
DE3481120D1 (de) * 1983-04-01 1990-03-01 Warner Lambert Co 3,6-disubstituierte-1,8-naphthalimide, verfahren zu ihrer herstellung und ihre verwendung.
DE3614414A1 (de) * 1986-04-29 1987-11-05 Knoll Ag Neue benzo(de)isochinolin-1,3-dione, ihre herstellung und verwendung
US4782064A (en) * 1986-07-21 1988-11-01 American Cyanamid Co. 2-heteroaryl-alkyl-1H-benz[de]-isoquinoline-1,3(2H)-diones

Also Published As

Publication number Publication date
CA1331382C (en) 1994-08-09
EP0268093A1 (de) 1988-05-25
AU7999087A (en) 1988-04-28
DE3779053D1 (enExample) 1992-06-17
ATE76069T1 (de) 1992-05-15
DE3635711A1 (de) 1988-04-28
JPS63104963A (ja) 1988-05-10
AU592474B2 (en) 1990-01-11
EP0268093B1 (de) 1992-05-13
ZA877859B (en) 1989-06-28
US5552544A (en) 1996-09-03

Similar Documents

Publication Publication Date Title
ES2037055T3 (es) Procedimiento para la obtencion de 5-nitrobenzo(de)isoquinolin-1,3-dionas.
ES527776A0 (es) Procedimiento de preparacion de derivados de 1,4-dihidropiridinas.
ES2016957B3 (es) Procedimiento para la obtencion de n,n'-diarilreas.
ES519423A0 (es) Procedimiento para preparar 9-(1 o 3-monoaciloxi-o 1,3-diaciloxi-2-propoximetil)-purinas substituidas en calidad de agentes antiviricos.
ES519367A0 (es) Procedimiento para preparar derivados de ciclohexano-1,3-diona.
ES2032299T3 (es) Procedimiento para obtener derivados de metil-penicilina 3-beta-sustituida.
ES517281A0 (es) Procedimiento para la obtencion de 4,4'-diisocianatodifenilmetano.
ES520812A0 (es) Procedimiento para la preparacion de 3-azolil-1,2-diaril-1-halogeno-1-propenos.
ES510596A0 (es) Procedimiento para la obtencion de 3-alquen-i-il-2,3-dimetil-ciclopropancarboxilatos de 4-fluor-3-fenoxi-bencilo.
IT8220803A0 (it) Procedimento per la preparazione del 2,3-diidro-2,2-dimetilbenzofuran-7olo.
ES503653A0 (es) Procedimiento para la obtencion de 2,4-dioxa-7,10-metano-espiro s',s-undecanos.
ES519366A0 (es) Procedimiento para preparar derivados de ciclohexano-1,3-diona-5-fenil-sustituidos.
ES520201A0 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina.
ES524714A0 (es) Procedimiento para la obtencion dederivados de 4h-1,4-benzotiazina.
ES521346A0 (es) Procedimiento para preparar las (2,3-dihidro(1,4-benzodioxin-2-il) alcoil) piperidin-4-il-(n-ciano-n'-r) guanidinas.
ES520847A0 (es) Procedimiento para la preparacion de 1,2,4-triazol-1-il-propionitrilos.
ES532108A0 (es) Procedimiento para preparar 9-(1 o 3-monoaciloxi-o 1,3-diaciloxi-2-propoximetil)-purinas substituidas en calidad de agentes antiviricos.
ES507317A0 (es) Procedimiento para la preparacion de derivados de la hexahi-dro-2,3,3,4,5.6-1h-indol(3,2,1-de)(naftiridina-1,5)
ES519659A0 (es) Procedimiento para la obtencion de 4,6-dioxa-5-etil-metiltriciclo.
ES523330A0 (es) Procedimiento para la obtencion de derivados de bencilurea.
ES525249A0 (es) Procedimiento para la obtencion de 1,3 tiazolidinas sustituidas.
ES507200A0 (es) Procedimiento para la fabricacion de derivados de la 5,6,7.8-tetrahidro-1,6-naftiridina.
ES512696A0 (es) "procedimiento de obtener compuestos metilquinoxalin-1,4-dioxidicos".
ES492796A0 (es) Procedimiento para la preparacion de 4-oxa-6-aza-6(fenil-es-piro)(2.4)heptan-5,7-dionas
IT8223632A0 (it) Procedimento per la preparazione di 2,2-dialchilamino-1-nitroeteni.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 268093

Country of ref document: ES